Edward Kim
Pre-Doctoral Trainee
Boston University School of Medicine, Division of Graduate Medical Sciences
Dept of Pharmacology & Experimental Therapeutics




Pre-Doctoral Trainee
Boston University School of Medicine, Division of Graduate Medical Sciences
Department of Program in Biomedical Neuroscience




p300 Mediates Melanoma Cell Growth and Survival Through the Transcriptional Regulation of MITF
01/01/2017 - 12/31/2017 (PI)
American Skin Association




Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Moriarty WF, Kim E, Gerber SA, Hammers H, Alani RM. Neuropilin-2 promotes melanoma growth and progression in vivo. Melanoma Res. 2016 Aug; 26(4):321-8.View Related Profiles. PMID: 26881875; DOI: 10.1097/CMR.0000000000000190;.
  2. Kim E, Wang Y, Kim SJ, Bornhorst M, Jecrois ES, Anthony TE, Wang C, Li YE, Guan JL, Murphy GG, Zhu Y. Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. Elife. 2014; 3. PMID: 25535838; PMCID: PMC4297949; DOI: 10.7554/eLife.05151;.
  3. Wang Y, Kim E, Wang X, Novitch BG, Yoshikawa K, Chang LS, Zhu Y. ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities. Cell. 2012 Aug 17; 150(4):816-30. PMID: 22901811; PMCID: PMC3427010; DOI: 10.1016/j.cell.2012.06.034;.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 3 publications over 3 distinct years, with a maximum of 1 publications in 2012 and 2014 and 2016

YearPublications
20121
20141
20161
Contact for Mentoring:


Kim's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department